EU, US to review Pfizer's application under parallel QbD evaluation pilot
This article was originally published in SRA
Executive Summary
The European Medicines Agency and the US Food and Drug Administration have agreed to assess the first marketing application under their pilot programme to evaluate in parallel the parts of the application concerning quality by design (QbD)1.